From the 13th to the 16th of December 2023, the second edition of the Catalan Week of Simulation was held. This event, emblematic in its focus on clinical safety, is distinguished by the use of simulation as a fundamental tool for medical training and preparation.
Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
Sentinel lymph node (SLN) biopsy has recently been accepted to assess lymph node status in early-stage endometrial cancer, which is key to tailoring adjuvant treatments. However, it is unknown to what extent…
To assess the safety and efficacy of adjuvant add-on treatments offered to improve assisted reproductive outcomes, the European Society of Human Reproduction and Embryology (ESHRE) appointed a multidisciplinary working group of clinicians…
A group of researchers at Dexeus Mujer, led by Dr. Gerard Albaiges, director of R&D of the Fetal Medicine Section of the Obstetrics Department, has conducted a prospective study to externally validate the Fetal Medicine Foundation (FMF) small-for-gestational-age…
A new multicentre study led by Dr. Nikolaos Polyzos, Head in the Dexeus Mujer Reproduction Service, has studied whether there could be any association between different genetic variants in the FSHR sequence and the outcomes of reproductive treatments…
The diagnosis of breast cancer is based on the study of images obtained from mammograms. However, in the case of dense or fibrous breasts, it is more difficult and it is often necessary to carry out other complementary tests. In fact, according to Dexeus Mujer statistics…
Two members of the Dexeus Mujer team, Dr Francesc Tresserra, director of Gynaecology R&D, and Dr Carmen Ara, specialist in Gynaecological Oncology and Breast Pathology, are part of the group of experts who have carried out the pilot programme to…
The Department of Obstetrics, Gynaecology and Reproductive Medicine in Dexeus Mujer is a Teaching Unit in the Hospital Universitari Dexeus recognised by the National Programme for Medical Intern Residents (MIR). Over the past 40 years, more than 200 resident doctor have chosen…
Doctors Pere Barri Soldevila, Núria Barbany and Rafael Fábregas from Dexeus Mujer, specialists in Endometriosis, Gynaecological Laparoscopy and Gynaecological Oncology, have been part of the teaching team that has offered a training course to other surgeons on vNOTES…
On 26 May, an event was held in the auditorium of the Hospital Universitario Dexeus to welcome the new resident doctors (MIR). At the same event, a Diploma was awarded to the MIRs completing their training this year.
An observational study led by the embryologist Lluc Coll analysed whether the prevalence of mosaic embryos in ART cycles with preimplantation genetic testing for aneuploidy (PGT-A) is associated with the trophectoderm biopsy technique used or with the time elapsed until the tubing of the sample.
Twin pregnancies are associated with higher rates of obstetric complications, preterm birth and perinatal morbidity and mortality than singleton pregnancies. But does the mode of conception have an impact on twin pregnancy outcomes? A retrospective study led by Dr Pilar Prats analysed a cohort of 1135 spontaneous…
A retrospective study led by Dr Gemma Sesmilo analysed whether women who use assisted reproductive technology have a higher incidence of gestational diabetes than those who become pregnant spontaneously. The research also assessed whether…
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
® Copyright 2021-2024 Dexeus Mujer Foundation – Gran Via Carles III 71-75. 08028 Barcelona. Spain
